Elanco CEO On $1.7B Market For Canine Dermatology

“The #1 reason people take their dogs to the vet is itching,” says Jeffrey Simmons, CEO of Elanco Animal Health, discussing Zenrelia’s FDA approval. Zenrelia is a once-daily oral medication that treats some allergic & dermatological conditions in dogs. He also discusses medication affordability for pets.

Morning Trade Live

30 Sep 2024

SHARE

Schwab Network's Newsletters

Daily insights for every investor